Title (en)

TRANSDERMAL DEVICE CONTAINING (E)-2-(P-FLUOROPHENETHYL)-3-FLUOROALLYLAMINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE

Title (de)

TRANSDERMALES SYSTEM ENTHALTEND (E)-2-(P-FLUOROPHENETHYL)-3-FLUOROALLYLAMIN ZUR BEHANDLUNG DER ALZHEIMERSCHEN KRANKHEIT

Title (fr)

DISPOSITIF TRANSDERMIQUE CONTENANT (E)-2-(P-FLUOROPHENETHYLE)-3-FLUOROALLYLAMINE ET SERVANT AU TRAITEMENT DE LA MALADIE D'ALZHEIMER

Publication

EP 0720475 A1 19960710 (EN)

Application

EP 94926566 A 19940823

Priority

• US 9409517 W 19940823
• US 12719093 A 19930924

Abstract (en)

[origin: WO9508325A1] The present invention relates to a method of treatment for Alzheimer's disease in a patient in need thereof comprising transdermally administering to said patient a therapeutically effective amount of (E)-2-(p-fluorophenethyl)-3-fluoroallylamine or a pharmaceutically acceptable salt thereof. Also provided is a transdermal device for administration of (E)-2-(p-fluorophenethyl)-3-fluoroallylamine or a pharmaceutically acceptable salt thereof.

IPC 1-7

A61K 31/135; A61K 9/70

IPC 8 full level

A61K 9/70 (2006.01); A61K 31/135 (2006.01); A61P 17/00 (2006.01); A61P 25/28 (2006.01)

CPC (source: EP)

A61K 9/7061 (2013.01); A61K 31/135 (2013.01); A61P 17/00 (2017.12); A61P 25/28 (2017.12)

Citation (search report)

See references of WO 9508325A1

Designated contracting state (EPC)

AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 9508325 A1 19950330; AU 684545 B2 19971218; AU 7636494 A 19950410; CA 2172605 A1 19950330; CN 1131390 A 19960918; EP 0720475 A1 19960710; HU 9600725 D0 19960528; HU T75877 A 19970528; IL 111017 A0 19941128; JP H09505276 A 19970527; NO 961180 D0 19960322; NO 961180 L 19960322; ZA 947262 B 19950523

DOCDB simple family (application)

US 9409517 W 19940823; AU 7636494 A 19940823; CA 2172605 A 19940823; CN 94193473 A 19940823; EP 94926566 A 19940823; HU 9600725 A 19940823; IL 11101794 A 19940921; JP 50976495 A 19940823; NO 961180 A 19960322; ZA 947262 A 19940919